BOSTON (EGMN) – A point-of-care assay that assesses platelet inhibition levels may be helpful for rapidly identifying trauma patients who might not respond to platelet reversal therapies or antiplatelet management, reported Dr. Vishal Bansal.
BOSTON (EGMN) – A point-of-care assay that assesses platelet inhibition levels may be helpful for rapidly identifying trauma patients who might not respond to platelet reversal therapies or antiplatelet management, reported Dr. Vishal Bansal.